Biomea Fusion Inc. Company Profile
NASDAQ: BMEAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.37+0.05 (+3.79%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
After hours: 1.38 +0.73%
Biomea Fusion at a glance
Biomea Fusion Inc. (NASDAQ: BMEA) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector. The company's shares have traded publicly since 2021. At a market capitalization of $95.4 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001840439, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- Biomea Fusion Inc.
- Ticker
- NASDAQ: BMEA
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Headquarters
- United States
- IPO year
- 2021
- Market cap
- $95.44M
- SEC CIK
- 0001840439
Companies similar to Biomea Fusion
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| OKUROnKure Therapeutics Inc. Class A | 2.30 | -2.13% | $93.14M | vs BMEA |
| EQEquillium Inc. | 1.44 | +3.60% | $91.31M | vs BMEA |
| PLYXPolaryx Therapeutics Inc. | 2.00 | -4.31% | $99.69M | vs BMEA |
| RLYBRallybio Corporation | 16.99 | +0.35% | $90.26M | vs BMEA |
| KZIAKazia Therapeutics Limited ADR | 8.82 | -5.06% | $100.79M | vs BMEA |
| ANIXAnixa Biosciences Inc. | 2.91 | -1.36% | $101.16M | vs BMEA |
| CRBPCorbus Pharmaceuticals Holdings Inc. | 5.27 | -4.01% | $101.93M | vs BMEA |
| MISTMilestone Pharmaceuticals Inc. | 0.7121 | -5.96% | $88.66M | vs BMEA |